Establishment of the induced pluripotent stem cell line PLAFMCi006-A from peripheral blood mononuclear cells of polycystic kidney disease patients with PKD2 gene mutation

作者：Yuxiang Ma, Shunlai Shang, Meihan Shi, Yunzhao Yang, Qinggang Li, Xueyuan Bai · 发表于：Stem Cell Research · 年份：2022 · DOI：10.1016/j.scr.2022.102681 · 被引用次数：2 · 研究领域：Renal and related cancers、Genetic and Kidney Cyst Diseases、Pluripotent Stem Cells Research

Polycystic kidney disease (PKD) caused by PKD2 mutation is an important type of autosomal dominant PKD. In this study, peripheral blood mononuclear cells from a patient with PKD2 polycystic kidney disease were reprogrammed to obtain induced pluripotent stem cells (iPSCs). After stable amplification, the pluripotency of the iPSCs was determined by identifying their cell-surface markers, their expression of pluripotency-related genes, and their ability to form teratomas with three germ layers in vivo. The establishment of the iPSC line could provide a basis for a kidney-like organ model of human PKD caused by PKD2 mutation for use in studying the pathogenesis of PKD along with relevant screening and testing intervention drugs.